Stacy Arnold

Stacy Arnold has served as Vice President, Product Development & Clinical Research since January 2024 leading new product development, program management, and the clinical organization. Ms. Arnold brings more than 18 years of diverse R&D, Clinical, PMO, and business experience in the biotechnology industry. She joined Axogen in April 2018 as Vice President, Program Management. In 2019, Ms. Arnold was appointed Vice President, Clinical Research where she led the research, development, and execution of clinical strategies to strengthen and advance the body of scientific evidence of new technologies and clinical applications to restore nerve function and quality of life to patients with peripheral nerve injuries. Prior to joining Axogen, Ms. Arnold most recently served as Senior Director of R&D and Program Management at Artivion (formerly CryoLife) driving global innovation and new product development of medical devices, biologics, and tissue technologies, while leading successful program management processes and business strategies to drive growth and deliver shareholder value. Prior to 2006, Stacy held technical and leadership roles at Safe Alert Technologies. Ms. Arnold serves as a Board Member on Mercer University’s National Engineering Advisory Board. She has an M.S. in Engineering from University of Toledo and a B.S. in Biomedical Engineering from Mercer University. She also holds a global Project Management Professional License from the Project Management Institute.